2001-04-30
org.kosen.entty.User@374c4fd6
이주현(@@@zelator)
발행기관
Richard E. Rowberg
발행일
2001/04/02
첨부파일
A central element of the debate about inclusion of
prescription drug benefits in Medicare is the price of
prescription drugs. A key issue in the debate concerns the
relatinship between those prices and the pharmaceutical
research and development (R&D) costs. While this report will
not analyze that relationship directly, it does present a
description and assessment of the pharmaceutical R&D(drug
development) process and the factors that affect costs. Such
an analysis should be useful in addressing questions about the
cost of pharmaceutical R&D and the dependence of prescription
drug prices in the United States on those costs.
-
리포트 평점
해당 콘텐츠에 대한 회원님의 소중한 평가를 부탁드립니다. -
0.0 (0개의 평가)